In this study, we utilized a large claims database to compare the incidence of mental health disorders in patients following a diagnosis of stage I testis cancer. We excluded any patient who recurred for stage I disease, thus emphasizing a cohort of patients who were essentially cured by orchiectomy. We then compared the incidence of newly diagnosed mental health disorders in this group to a matched cohort of patients who had an orchiectomy for a benign etiology. A propensity score match was performed to control for factors that can impact mental health outcomes, including age, ethnicity, and prior testosterone or antidepressant use. Our study found that patients diagnosed with stage I testicular cancer and cured by orchiectomy had significantly higher rates of mental health disorders, specifically a 2.7-fold higher relative risk of developing depression, 2.5-fold higher risk of anxiety, and 2.5-fold higher risk of sleep disorders compared to the control population.
This data highlights that even in a population of early-stage testicular cancer patients who have been cured, mental health disorders were significant and prevalent. These findings underscore the critical importance of mental health evaluation even in early-stage disease, an area that remains understudied and requires further dedicated investigation. Furthermore, it is essential that urologists, who are often the primary providers for these patients, actively screen for these disorders and initiate a multidisciplinary approach involving mental health professionals to ensure comprehensive survivorship care.
Written by: Jersey-Kate Castillo,1 and Muhannad Alsyouf,1,2
- Department of Urology, Loma Linda University Health, Loma Linda, CA
- Division of Urology, Riverside University Health System, Moreno Valley, CA